Purpose

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Conditions

Eligibility

Eligible Ages
Between 5 Years and 120 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female reported in database and not an invalid entry - Age reported and not an invalid entry - Treatment date of November 01, 2008 or later.

Exclusion Criteria

• Incomplete information on treatment parameters

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
Patients treated with NeuroStar TMS
  • Device: NeuroStar Advanced TMS Therapy System
    non-invasive brain stimulation device

Recruiting Locations

More Details

Status
Recruiting
Sponsor
Neuronetics

Study Contact

Neha Goyal
763-528-1599
neha.goyal@neurostar.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.